The Board of Directors of AMAG Pharmaceuticals, Inc. has authorized a buyback plan on January 6, 2016.
1st Jan change | Capi. | |
---|---|---|
+62.91% | 856B | |
+39.32% | 631B | |
-3.83% | 359B | |
+17.98% | 325B | |
+8.98% | 297B | |
+5.89% | 234B | |
+16.79% | 226B | |
+16.10% | 177B | |
+1.86% | 165B |
The Board of Directors of AMAG Pharmaceuticals, Inc. has authorized a buyback plan on January 6, 2016.
1st Jan change | Capi. | |
---|---|---|
+62.91% | 856B | |
+39.32% | 631B | |
-3.83% | 359B | |
+17.98% | 325B | |
+8.98% | 297B | |
+5.89% | 234B | |
+16.79% | 226B | |
+16.10% | 177B | |
+1.86% | 165B |